FDA approves Intercell's Ixiaro

FDA approved a BLA for Ixiaro from Intercell (VSE:ICLL) to prevent Japanese encephalitis. The company expects partner Novartis (NYSE:NVS; SIX:NOVN) to launch the vaccine in the U.S. next quarter. The ...